This story originally ran on Dec. 17.

Thermo Fisher Scientific this week announced a collaboration between its Biomarker Research Initiatives in Mass Spectrometry center and Expression Pathology to develop assays for identifying cancer protein biomarkers.

Under the terms of the collaboration, the two firms will apply Thermo Fisher's expertise in protein analysis by mass spectrometry and Expression Pathology's sample preparation technology for formalin-fixed paraffin embedded tissue to develop single-reaction monitoring assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.